Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung

Kang,Jiun

doi:10.3892/etm.2014.2123

Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung

Authors:
- Jiun Kang
View Affiliations

Affiliations: Department of Biomedical Laboratory Science, Korea Nazarene University, Cheonan 330‑718, Republic of Korea
Published online on: December 9, 2014 https://doi.org/10.3892/etm.2014.2123
Pages: 345-350
Copyright: © Kang . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genetic alterations in the early stages of cancer have a close correlation with tumor initiation and potentially activate downstream pathways implicated in tumor progression; however, the method of initiation in sporadic neoplasias is largely unknown. In this study, whole‑genome microarray‑comparative genomic hybridization was performed to identify the early genetic alterations that define the prognosis of patients with stage I squamous cell carcinoma (SCC) of the lung. The most striking finding was the high frequency of copy number losses and hemizygous deletions on chromosome 8p, which occurred in 94.7% (18/19) and 63.2% (12/19) of the cases, respectively, with a delineated minimal common region of 8p21.1‑p23.3. More specifically, three loci of homozygous deletions at 8p23.1 were noted in 21.1% (4/19) of the cases. This region contains the following possible target genes, which have previously not been implicated to play a pathogenic role in stage I SCCs: MSRA, MFHAS1, CLDN23, DEFB106A, DEFB105A, LOC441316, FAM90A7P and LOC441318. These findings indicate that genetic alterations on chromosome 8p may be the first step in the initiation of genomic instability in early SCCs, and the newly identified genes in the 8p23.1 chromosomal region might be of interest for the study of the pathophysiology of stage I SCC, as potential targets for therapeutic measures.

View Figures

View References

1	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
2	Kang JU, Koo SH, Kwon KC, Park JW and Kim JM: Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet. 182:1–11. 2008. View Article : Google Scholar : PubMed/NCBI
3	Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S and Lam WL: Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet. 14:475–482. 2005. View Article : Google Scholar
4	Iwakawa R, Kohno T, Kato M, Shiraishi K, Tsuta K, Noguchi M, Ogawa S and Yokota J: MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis. Clin Cancer Res. 17:1481–1489. 2011. View Article : Google Scholar
5	Yan WS, Song LY, Wei WD, Li A, Liang QW, Liu JH and Fang Y: Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking. Ai Zheng. 24:47–52. 2005.(In Chinese). PubMed/NCBI
6	Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan B, Pang E, Johnson PJ and Yim A: Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer. 40:1082–1094. 2004. View Article : Google Scholar : PubMed/NCBI
7	Mihailovici MS, Danciu M, Teleman S, Stanciu C, Stan M, Bălan G and Potoroacă A: Diagnosis of gastric cancer on endobiopsies using the WHO classification. Rev Med Chir Soc Med Nat Iasi. 106:725–729. 2002.(In Romanian).
8	Hwang KT, Han W, Cho J, Lee JW, Ko E, Kim EK, Jung SY, Jeong EM, Bae JY, Kang JJ, Yang SJ, Kim SW and Noh DY: Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer. 123:1807–1815. 2008. View Article : Google Scholar : PubMed/NCBI
9	Park JJ, Kang JK, Hong S, Ryu ER, Kim JI, Lee JH and Seo JS: Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells. Gene. 407:139–147. 2008. View Article : Google Scholar
10	Choi YW, Choi JS, Zheng LT, Lim YJ, Yoon HK, Kim YH, Wang YP and Lim Y: Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. Lung Cancer. 55:43–51. 2007. View Article : Google Scholar
11	Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS and Ahn WS: Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer. 17:687–696. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kang JU, Koo SH, Kwon KC and Park JW: Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol. 37:327–335. 2010.PubMed/NCBI
13	Willenbrock H and Fridlyand J: A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics. 21:4084–4091. 2005. View Article : Google Scholar : PubMed/NCBI
14	Lei KF, Wang YF, Zhu XQ, et al: Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer. 7:1722007. View Article : Google Scholar : PubMed/NCBI
15	Katoh M: Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol. 27:1677–1683. 2005.PubMed/NCBI
16	Katoh M and Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med. 11:683–689. 2003.PubMed/NCBI
17	Alonso Guervós M, Alvarez Marcos C, Llorente JL, Sampedro Nuño A, Suárez C and Hermsen M: Genetic differences between primary larynx and pharynx carcinomas and their matched lymph node metastases by multiplex ligation-dependent probe amplification. Oral Oncol. 45:600–604. 2009. View Article : Google Scholar
18	Kang JU, Koo SH, Kwon KC, Park JW and Kim JM: Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer. 9:2372009. View Article : Google Scholar : PubMed/NCBI
19	Shao SJ, Wang Y and Yang PM: Abnormalities of molecular biology in premalignant lung lesions. Ai Zheng. 23:99–103. 2004.PubMed/NCBI
20	Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L, et al: An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene. 28:2773–2783. 2009. View Article : Google Scholar : PubMed/NCBI
21	Moore LE, Jaeger E, Nickerson ML, et al: Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis. 1:e142012. View Article : Google Scholar : PubMed/NCBI
22	Cheng I, Levin AM, et al: Copy number alterations in prostate tumors and disease aggressiveness. Genes Chromosomes Cancer. 51:66–76. 2012. View Article : Google Scholar
23	El-Naggar AK, Coombes MM, Batsakis JG, Hong WK, Goepfert H and Kagan J: Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene. 16:2983–2987. 1998. View Article : Google Scholar : PubMed/NCBI
24	Huang J, Zheng DL, Qin FS, Cheng N, Chen H, Wan BB, Wang YP, Xiao HS and Han ZG: Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest. 120:223–241. 2010. View Article : Google Scholar :
25	Kurimoto F, Gemma A, Hosoya Y, Seike M, Takenaka K, Uematsu K, Yoshimura A, Shibuya M and Kudoh S: Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer. Int J Mol Med. 8:89–93. 2001.PubMed/NCBI
26	Shao S, Sun W, Zhang J, An Q, Xiao T, Yang P, Cheng S and Gao Y: Fine deletion mapping on chromosome 8p21-8p22 in adenocarcinoma of lung. Zhonghua Yi Xue Za Zhi. 82:740–742. 2002.(In Chinese). PubMed/NCBI
27	Wistuba II, Behrens C, Virmani AK, et al: Allelic losses at chromosome 8 p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59:1973–1979. 1999.PubMed/NCBI
28	Castro M, Grau L, Puerta P, et al: Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. 8:862010. View Article : Google Scholar : PubMed/NCBI
29	Yuan BZ, Jefferson AM, et al: DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene. 23:1405–1411. 2004. View Article : Google Scholar
30	Kim TY, Jackson S, Xiong Y, Whitsett TG, Lobello JR, Weiss GJ, Tran NL, Bang YJ and Der CJ: CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth. Proc Natl Acad Sci USA. 110:16868–16873. 2013. View Article : Google Scholar : PubMed/NCBI
31	Pils D, Horak P, Vanhara P, Anees M, Petz M, Alfanz A, Gugerell A, Wittinger M, Gleiss A, Auner V, Tong D, Zeillinger R, Braicu EI, Sehouli J and Krainer M: Methylation status of TUSC3 is a prognostic factor in ovarian cancer. Cancer. 119:946–954. 2013. View Article : Google Scholar
32	Vaňhara P, Horak P, Pils D, Anees M, Petz M, Gregor W, Zeillinger R and Krainer M: Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells. Int J Oncol. 1383–1389. 2013.
33	Li X, Liu H, Yu T, Dong Z, Tang L and Sun X: Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis. Neoplasma. 61:128–135. 2014. View Article : Google Scholar
34	Lei KF, Wang YF, Zhu XQ, Lu PC, Sun BS, Jia HL, Ren N, Ye QH, Sun HC, Wang L, Tang ZY and Qin LX: Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer. 7:1722007. View Article : Google Scholar : PubMed/NCBI